Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Aligos Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +7 vs. Q3 2024
- Shares held
- 1.62M
- −72.7K (−4.3%) vs. Q3 2024
- Total value
- $64.5M
- +$49.9M (+340.3%) vs. Q3 2024
- New holders
- 13
- 10 more added
- Sold out
- 6
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 325,000 | $12.9M | 0.02% | +106,187+48.5% | Added |
| EcoR1 Capital, LLC | 255,573 | $10.2M | 0.41% | 00.0% | Unchanged |
| Deep Track Capital, LP | 244,110 | $9.73M | 0.36% | 00.0% | Unchanged |
| Vivo Capital, LLC | 141,879 | $5.65M | 0.63% | 00.0% | Unchanged |
| Vanguard Group Inc | 96,762 | $3.85M | 0.00% | +32,948+51.6% | Added |
| Baker Bros. Advisors LP | 83,055 | $3.31M | 0.04% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 76,247 | $3.04M | 0.11% | 00.0% | Unchanged |
| Trexquant Investment LP | 69,050 | $2.75M | 0.03% | +69,050 | New |
| Ikarian Capital, LLC | 64,300 | $2.56M | 0.73% | +64,300 | New |
| UBS Oconnor LLC | 40,096 | $1.60M | 0.04% | −27,000−40.2% | Reduced |
| Avantax Advisory Services, Inc. | 30,570 | $1.22M | 0.01% | +30,570 | New |
| Geode Capital Management, LLC | 27,253 | $1.09M | 0.00% | +3,197+13.3% | Added |
| Drive Wealth Management, LLC | 23,000 | $916.3K | 0.22% | +23,000 | New |
| Royal Bank of Canada | 23,008 | $916.0K | 0.00% | +23,008 | New |
| Wells Fargo & Company | 21,800 | $868.5K | 0.00% | +21,800 | New |
| Boothbay Fund Management, LLC | 18,543 | $738.8K | 0.02% | +18,543 | New |
| UBS Group AG | 15,521 | $618.4K | 0.00% | +15,507+110,764.3% | Added |
| Charles Schwab Investment Management Inc | 14,286 | $569.2K | 0.00% | +2,306+19.2% | Added |
| BlackRock, Inc. | 13,721 | $546.6K | 0.00% | +4,654+51.3% | Added |
| Renaissance Technologies LLC | 11,443 | $455.9K | 0.00% | −2,000−14.9% | Reduced |
| State Street Corp | 9,582 | $381.7K | 0.00% | +9,582 | New |
| Northern Trust Corp | 5,157 | $205.5K | 0.00% | +5,157 | New |
| Morgan Stanley | 3,233 | $128.8K | 0.00% | +3,099+2,312.7% | Added |
| Golden State Wealth Management, LLC | 2,674 | $106.5K | 0.02% | +2,674 | New |
| AlphaMark Advisors, LLC | 1,100 | $44.0K | 0.02% | +1,000+1,000.0% | Added |
| Advisor Group Holdings, Inc. | 895 | $35.7K | 0.00% | +675+306.8% | Added |
| Tower Research Capital LLC (TRC) | 652 | $26.0K | 0.00% | +622+2,073.3% | Added |
| Bank of America Corp | 285 | $11.4K | 0.00% | −6,566−95.8% | Reduced |
| Spire Wealth Management | 200 | $7.97K | 0.00% | +200 | New |
| SBI Securities Co., Ltd. | 171 | $6.81K | 0.00% | +171 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 80 | $3.19K | 0.00% | +80 | New |
| JPMorgan Chase & Co | 26 | $1.04K | 0.00% | 00.0% | Unchanged |
| ZRC Wealth Management, LLC | 4 | $160 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3 | $120 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −315,095−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −91,971−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −30,597−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −26,219−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −10,947−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −675−100.0% | Sold out |